LISA REINHARDT: Open Payments
NPI 1982166203 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 104 payments from 18 companies in 2025. Trend: 2023 $1,259 · 2024 $1,516 · 2025 $1,705
Food & beverage: $1,605Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $337 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $219 |
| Otsuka America Pharmaceutical, Inc. | 15 | $194 |
| Alkermes, Inc. | 14 | $169 |
| Neurocrine BioSciences, Inc. | 12 | $154 |
| Axsome Therapeutics, Inc. | 6 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $111 |
| Collegium Pharmaceutical, Inc. | 4 | $74 |
| Corium, LLC | 5 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
Products named: CAPLYTA, AUSTEDO XR, ARISTADA, INGREZZA, Auvelity, REXULTI, FANAPT, UZEDY.
Industry payments across IN — which companies pay providers there.
